Brain-Targeted nausea drug tested for faster ER relief
NCT ID NCT06740812
Summary
This study aims to find out if a newer nausea medication (fosaprepitant) works better and is safer than a commonly used drug (metoclopramide) for adults in the emergency room. Researchers will randomly assign 212 patients with moderate to severe nausea to receive one of the two drugs and then track their relief and any new side effects over 24 hours. The goal is to see if the newer drug provides faster, longer-lasting relief without the heart-related risks sometimes linked to current treatments.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NAUSEA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Montefiore Medical Center
The Bronx, New York, 10467, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.